Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 4/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10063953 | 1.00 | TP53 (0.43) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063977 | 1.00 | TP53 (0.43) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063904 | 0.98 | PTGES (0.44) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063930 | 0.98 | TP53 (0.43) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063899 | 0.97 | TP53 (0.43) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL9963841 | 0.91 | PTGES (0.40) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10064003 | 0.91 | KIF11 (0.40) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10064012 | 0.91 | KIF11 (0.40) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063876 | 0.90 | KIF11 (0.39) | TP53SMN1; SMN2PTGESALOX5TNKS | |
| SCHEMBL10063874 | 0.90 | KIF11 (0.39) | TP53SMN1; SMN2PTGESALOX5TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110122-B2 | Anthracene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-8110122-B2 | Anthracene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100051926-A1 | Anthracene Derivative, Material for Light-Emitting Element, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-04 | — | — | US | disclosed |
| US-20100051926-A1 | Anthracene Derivative, Material for Light-Emitting Element, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051926-A1 | Anthracene Derivative, Material for Light-Emitting Element, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | NR2E3, ARL1, RER1 | TP53 4639/4885SMN1; SMN2 2557/4885PTGES 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.